Victoza
Sponsors
Bispebjerg Hospital, Hanmi Pharmaceutical Company Limited, University at Buffalo, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Carmot Therapeutics, Inc.
Conditions
Diabetes MellitusMicrovascular DysfunctionType 1 DiabetesType 2 Diabetes
Phase 1
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
NCT02059564
Start: 2013-12-31End: 2014-12-31Target: 44Updated: 2014-02-11
Human Bioequivalence Test of Liraglutide Injection
CompletedNCT05029076
Start: 2019-05-21End: 2019-07-01Updated: 2021-08-31
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
CompletedNCT05794581
Start: 2023-03-21End: 2024-04-06Updated: 2024-12-27